Abstract: The invention relates to novel triazolotriazinones of the general formula and to a method for their production and pharmaceutical use thereof.

Abstract: The invention relates to novel sulfonamides of general formula (I) where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.

Abstract: Novel imidazotriazinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed.

Abstract: What is disclosed is a computer-implemented method for finding objects which are based on data structures, the method comprising the following steps: announcing a selection of objects; generating and/or invalidating a characterization of one object or several objects of the selection, with characterization being effected by means of an item of characterization information; calculating weights of the objects of the selection and/or of objects located in a vicinity of the characterized objects based on the characterization information, weights already calculated, and/or weights already stored; and modifying the selection and continuing the method from the first step until objects to be found are contained in the selection, until the method is interrupted, or until a given or calculated number of method steps has been carried out, with the possibility of terminating or interrupting the method after any one of the preceding steps.

Abstract: The present invention relates to 7-alkyl- and cycloalkyl-substituted imidazotriazinones, to processes for their preparation and to their use as medicaments, in particular as inhibitors of cGMP-metabolizing phosphodiesterases.

Abstract: The invention relates to imidazo[1,3,5]triazinones, a method for their production and methods of use, in particular as inhibitors of cyclic GMP metabolizing phosphodiesterases.

Abstract: An array of hybridization probes, each of which comprises a mass label linked to a known base sequence of predetermined length, wherein each mass label of the array, optionally together with the known base sequence, is relatable to that base sequence by mass spectrometry.

Abstract: The invention relates to new indole derivatives, processes for their preparation, and their use in medicaments.

Abstract: Provided is a method for characterizing a polypeptide or a population of polypeptides, which method comprises: (a) contacting a sample comprising one or more polypeptides with a first cleavage agent to generate polypeptide fragments; (b) isolating one or more polypeptide fragments, each fragment comprising the N-terminus or the C-terminus of the polypeptide from which it was fragmented; (c) identifying the isolated fragments by mass spectrometry; (d) repeating steps (a)-(c) on the sample using a second cleavage agent that cleaves at a difference site from the first cleavage agent; and (e) characterizing the one or more polypeptides in the sample from the fragments identified in steps (c) and (d).

Abstract: The present invention relates to 7-alkyl- and cycloalkyl-substituted imidazotriazinones, to processes for their preparation and to their use as medicaments, in particular as inhibitors of cGMP-metabolizing phosphodiesterases.

Abstract: The invention relates to novel benzofuran derivatives, to processes for preparing them and to their uses in medicaments.

Abstract: The invention relates to imidazo[1.3.5]triazinones, a method for their production and methods of use, in particular as inhibitors of cyclic GMP metabolizing phosphodiesterases.

Abstract: The invention relates to novel diphenylmethane derivatives, processes for their preparation and their use in medicaments, in particular for the indications of arteriosclerosis and hypercholesterolaemia.

Abstract: The invention relates to new indole derivatives, processes for their preparation, and their use in medicaments.

Abstract: The present invention relates to novel sulphonamides of the general formula (I) 1

Abstract: The present invention relates to compounds of the general formula (I) in which X represents O, S, SO, SO2, CH2, CHF, CF2 or NR8, and Z represents a group of the formula in which A represents O or S, the subscript “a” is 0 or 1, group D represents a straight-chain (C1-C4)-alkylene group, and R36 represents OR37 or NR38R39. It also relates to processes for preparation of such compounds and to their use in medicaments for the treatment of depression, goiter, cancer of the thyroid gland, arteriosclerosis, hypercholesterolaemia, dyslipidaemia, obesity, cardiac insufficiency, pulmonary emphysema, pain, migraine, Alzheimer's disease, osteoporosis, cardiac arrhythmias, hypothyroidism, skin disorders or diabetes.

Abstract: The invention relates to novel isoxazolo pyrimidinones of general formula (I), a method for producing the same and the pharmaceutical use thereof.

Abstract: A computer-implemented method for navigating between sections in a display space is furnished, wherein the sections in the display space are each assigned to a particular location of the display space, and representatives are provided which are each assigned to a particular section in the display space by means of an unambiguous relation, said method comprising the following steps: selecting at least one representative that is assigned to a particular section in the display space with the aid of the unambiguous relation; and navigating to the particular section in the display space with the aid of the unambiguous relation with the particular section in the display space.

Abstract: Novel imidazotrizinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed.

Abstract: A method for fractal-darwinian object generation consists of the steps of: preparing a fractal object library including predetermined objects and associated rules of property and context, forming objects and comparing the formed objects with the objects in the fractal object library. By using the property rules, a local classification likelihood is allocated to each formed object. Thereupon, by using the context rules for each object, a respective fractal classification likelihood is formed. For optimisation of the fractal classification likelihood, alteration rules are applied to the objects. The above method is carried out iteratively, whereby a process of gradual optimisation takes place.